Form of presentation | Conference proceedings in international journals and collections |
Year of publication | 2017 |
|
Ziganshina Liliya Evgenevna, author
|
|
Kisar Lidiya Vyacheslavovna, postgraduate kfu
|
Bibliographic description in the original language |
Kisser LV., Ziganshina LE. |
Annotation |
Clinical practice guidelines (CPGs) became increasingly important in the Russian health environment as support tools for clinical decision making and interaction with health insurers. Over the last decades, a series of countrywide, guideline-like documents were developed and used mainly in health financing. However, not all health professionals are clear what guidelines are for, how they should be developed and used. Promotion of health technologies by manufacturers is a widespread and accepted reality, while the process/methodology of guideline development and assessment seem to be not fully established. |
Keywords |
Clinical practice guidelines,AGREE II,clinical pharmacology, methodological quality |
Place of publication |
Cape Town, South Africa |
Publishing house |
Cochrane Database of Systematic Reviews |
URL |
10.1002/14651858.CD201702 |
Please use this ID to quote from or refer to the card |
https://repository.kpfu.ru/eng/?p_id=159659&p_lang=2 |
Full metadata record |
Field DC |
Value |
Language |
dc.contributor.author |
Ziganshina Liliya Evgenevna |
ru_RU |
dc.contributor.author |
Kisar Lidiya Vyacheslavovna |
ru_RU |
dc.date.accessioned |
2017-01-01T00:00:00Z |
ru_RU |
dc.date.available |
2017-01-01T00:00:00Z |
ru_RU |
dc.date.issued |
2017 |
ru_RU |
dc.identifier.citation |
Kisser LV., Ziganshina LE. |
ru_RU |
dc.identifier.uri |
https://repository.kpfu.ru/eng/?p_id=159659&p_lang=2 |
ru_RU |
dc.description.abstract |
Clinical practice guidelines (CPGs) became increasingly important in the Russian health environment as support tools for clinical decision making and interaction with health insurers. Over the last decades, a series of countrywide, guideline-like documents were developed and used mainly in health financing. However, not all health professionals are clear what guidelines are for, how they should be developed and used. Promotion of health technologies by manufacturers is a widespread and accepted reality, while the process/methodology of guideline development and assessment seem to be not fully established. |
ru_RU |
dc.language.iso |
ru |
ru_RU |
dc.publisher |
Cochrane Database of Systematic Reviews |
ru_RU |
dc.subject |
Clinical practice guidelines |
ru_RU |
dc.subject |
AGREE II |
ru_RU |
dc.subject |
clinical pharmacology |
ru_RU |
dc.subject |
methodological quality |
ru_RU |
dc.title |
?Assessment of Russian clinical practice guidelines with the AGREE II instrument? |
ru_RU |
dc.type |
Conference proceedings in international journals and collections |
ru_RU |
|